Hangzhou Neoantigen Therapeutics Co., Ltd.
PrivateCompany Overview
Hangzhou Neoantigen Therapeutics Co., Ltd. operates in Healthcare & Life Sciences and is based in Hangzhou. It was founded in 2016.
Hangzhou Neoantigen Therapeutics Co., Ltd. is a biotechnology company that develops personalized neoantigen-based cancer immunotherapies, including peptide and mRNA vaccines.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Hangzhou Neoantigen Therapeutics Co., Ltd. Comparables
Compare Hangzhou Neoantigen Therapeutics Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Likang Life Sciences | 87% | |
| Anda Biopharma | 86% | |
| Geneos Therapeutics | 79% |
For institutional investors. Book with your work email.
Hangzhou Neoantigen Therapeutics Co., Ltd. Funding Rounds
Historical fundraising activity
Hangzhou Neoantigen Therapeutics Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Hangzhou Neoantigen Therapeutics Co., Ltd.'s valuation, stock price, and market status.
Is Hangzhou Neoantigen Therapeutics Co., Ltd. a public or private company?
Hangzhou Neoantigen Therapeutics Co., Ltd. is a private company.
What is the current stock price of Hangzhou Neoantigen Therapeutics Co., Ltd.?
Hangzhou Neoantigen Therapeutics Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Hangzhou Neoantigen Therapeutics Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Hangzhou Neoantigen Therapeutics Co., Ltd. worth (valuation)?
Valuation information for Hangzhou Neoantigen Therapeutics Co., Ltd. is not publicly available.
Can I buy Hangzhou Neoantigen Therapeutics Co., Ltd. stock?
Hangzhou Neoantigen Therapeutics Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Hangzhou Neoantigen Therapeutics Co., Ltd.'s last funding round?
Funding round information for Hangzhou Neoantigen Therapeutics Co., Ltd. is not publicly available.
Who are the main investors in Hangzhou Neoantigen Therapeutics Co., Ltd.?
Investor information for Hangzhou Neoantigen Therapeutics Co., Ltd. is not publicly disclosed.
Will Hangzhou Neoantigen Therapeutics Co., Ltd. IPO soon?
No public IPO plans have been announced for Hangzhou Neoantigen Therapeutics Co., Ltd..
How can I track Hangzhou Neoantigen Therapeutics Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Hangzhou Neoantigen Therapeutics Co., Ltd.'s shares on secondary markets.